STOCK TITAN

Point72 Affiliates Hold 7% of CYBN; Shared Voting/Dispositive Power

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Point72 affiliates reported holding 1,606,317 common shares of Cybin Inc., representing 7.0% of the outstanding class as of June 30, 2025. The filing lists Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen as reporting persons; each reports 0 sole voting or dispositive power and 1,606,317 shared voting and dispositive power. The statement clarifies that the shares are held by Point72 Associates, an investment fund managed by Point72 Asset Management, and that the filing is not an admission of beneficial ownership for Section 13 purposes. The signee is Jason M. Colombo, as authorized person, dated August 14, 2025.

Positive

  • Disclosure of a material 7.0% stake (1,606,317 shares) provides transparency for investors
  • Ownership reported as shared voting and dispositive power, indicating coordinated management through Point72 Associates rather than sole control

Negative

  • None.

Insights

TL;DR: Point72 reports a 7.0% passive stake in CYBN with shared voting and dispositive power as of June 30, 2025.

This Schedule 13G/A discloses that Point72-associated entities and Steven A. Cohen hold 1,606,317 shares, equal to 7.0% of Cybin Inc.'s common shares. The report indicates shared voting and dispositive power rather than sole control, and the certification asserts the position is not intended to influence control of the issuer. For investors, the filing signals a meaningful minority holding by an established investment manager without an expressed control intent.

TL;DR: This is a routine passive ownership disclosure showing shared authority, not a control or activist filing.

The form is filed under Schedule 13G/A and includes the required ownership breakdown: 0 sole voting/dispositive power and 1,606,317 shared voting/dispositive power for each reporting person. The certification language reiterates the filing is not for influencing control. From a governance perspective, this creates transparency around a >5% stake while signaling no current intent to seek control positions or engage in proxy contests.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2025

FAQ

What stake does Point72 report in Cybin Inc. (CYBN)?

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen each report beneficial ownership of 1,606,317 shares, representing 7.0% of Cybin Inc.'s common shares as of June 30, 2025.

Does Point72 claim sole voting or dispositive power over the CYBN shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power, and 1,606,317 shared voting and shared dispositive power for each reporting person.

Who holds the shares on behalf of Point72?

The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management, as stated in Item 2(a).

Does the filing indicate Point72 intends to influence control of Cybin?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

When is the ownership information reported as of?

The ownership amounts are reported as of the close of business on June 30, 2025.

Who signed the Schedule 13G/A for Point72 and Steven A. Cohen?

The filing is signed by Jason M. Colombo, Authorized Person, on behalf of Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen, dated August 14, 2025.
Cybin Inc

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Latest SEC Filings

CYBN Stock Data

407.14M
41.00M
98.65%
38.53%
10.87%
Biotechnology
Healthcare
Link
Canada
Toronto